Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score

<div>ITP diagnosis and treatment timeline. Major dates in the patient’s initial ITP presentation and treatment course occurring in 2019 are listed along the <i>x</i>-axis with accompanying hash marks and events above. Daily platelet counts (/<i>µ</i>L) and LDH (U/L) where available are listed below respective dates. The above timeline includes major therapies with which the patient was treated, spanning across dates received including prednisone 1 mg/kg (blue bar), IVIG (red bar), dexamethasone 40 mg (yellow bar), and romiplostim 120 mcg (green bar). Overlapping bars imply multiple treatments given on same days.</div>

Case Reports in Medicine

fig1

Figure 1

Figure 1: Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score 

Figure 1 | Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score 